Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

22.02
-2.1400-8.86%
Post-market: 22.220.2000+0.91%19:23 EDT
Volume:33.30M
Turnover:764.64M
Market Cap:5.01B
PE:42.98
High:24.25
Open:23.95
Low:21.70
Close:24.16
52wk High:70.43
52wk Low:13.74
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.92
T/O Rate:16.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5123
EPS(LYR):0.5123
ROE:25.23%
ROA:5.29%
PB:9.27
PE(LYR):42.98

Loading ...

Hims & Hers Shares Double on Report of Wegovy Tie-Up

Dow Jones
·
Mar 09

Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute

Dow Jones
·
Mar 09

Stock Track | Hims & Hers Health Soars 38.56% in Pre-Market on Novo Nordisk Partnership for Weight-Loss Drugs

Stock Track
·
Mar 09

Hims & Hers Health Shares up 37.9% Premarket After Report Novo to Sell Its Weight-Loss Drugs on Co's Platform

THOMSON REUTERS
·
Mar 09

24H|USO Soared 23%; Hims ​Surged 20%; INDO And USEG Up 18%; Battalion Oil Up 17%; SOC Up 13%; Figure And Circle Down 5%

Tiger Newspress
·
Mar 09

Novo and Hims Resolve Dispute, Will Sell Obesity Drugs Together, Bloomberg News Reports

Reuters
·
Mar 07

Hims & Hers Health Shares up 39% in After-Hours Trading After Report Co and Novo Will Sell Obesity Drugs Together

THOMSON REUTERS
·
Mar 07

BRIEF-Novo And Hims End Feud, Will Sell Obesity Drugs Together- Bloomberg News

Reuters
·
Mar 07

Novo and Hims Plan to Announce a New Partnership as Soon as Monday - Bloomberg News

THOMSON REUTERS
·
Mar 07

BUZZ-Hims & Hers Health falls; JP Morgan Chase cuts stake in co

Reuters
·
Mar 06

JPMorgan Chase & Co Cuts Share Stake in Hims & Hers Health to 1.7% as of Feb 27, 2026 From 8.1% as of Sept. 30, 2025 - SEC Filing

THOMSON REUTERS
·
Mar 06

Hims Hers Health 59% Revenue Growth Meets Margin Pressure From Global Expansion

Smartkarma
·
Mar 04

Strive Pharmacy says it will not resume compounded oral semaglutide sales

Reuters
·
Mar 04

Mixed options sentiment in Hims and Hers Health with shares down 1.49%

TIPRANKS
·
Mar 04

US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs

Reuters
·
Mar 04

Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports

Reuters
·
Mar 03

Hims & Hers Stock (HIMS) Surged 13.5% — Could More Gains Be Ahead?

TIPRANKS
·
Mar 03

Hims & Hers Health Chief Legal Officer Soleil Boughton Disposes of Common Shares

Reuters
·
Mar 03

Hims, Qualcomm, IBM, First Solar, Oracle Trending With Analysts

TIPRANKS
·
Feb 28

A Look At Hims & Hers (HIMS) Valuation After Regulatory Setbacks And Softer Revenue Outlook

Simply Wall St.
·
Feb 28